Ad is loading...
AIMD
Price
$0.44
Change
-$0.04 (-8.33%)
Updated
Nov 15 closing price
CODX
Price
$1.06
Change
-$0.04 (-3.64%)
Updated
Nov 15 closing price
142 days until earnings call
Ad is loading...

AIMD vs CODX

Header iconAIMD vs CODX Comparison
Open Charts AIMD vs CODXBanner chart's image
Ainos
Price$0.44
Change-$0.04 (-8.33%)
Volume$162.47K
CapitalizationN/A
Co-Diagnostics
Price$1.06
Change-$0.04 (-3.64%)
Volume$126.03K
CapitalizationN/A
AIMD vs CODX Comparison Chart
Loading...
AIMD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CODX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AIMD vs. CODX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIMD is a StrongSell and CODX is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (AIMD: $0.44 vs. CODX: $1.06)
Brand notoriety: AIMD and CODX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AIMD: 36% vs. CODX: 146%
Market capitalization -- AIMD: $6.73M vs. CODX: $34.7M
AIMD [@Medical Specialties] is valued at $6.73M. CODX’s [@Medical Specialties] market capitalization is $34.7M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AIMD’s FA Score shows that 0 FA rating(s) are green whileCODX’s FA Score has 1 green FA rating(s).

  • AIMD’s FA Score: 0 green, 5 red.
  • CODX’s FA Score: 1 green, 4 red.
According to our system of comparison, CODX is a better buy in the long-term than AIMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AIMD’s TA Score shows that 3 TA indicator(s) are bullish while CODX’s TA Score has 4 bullish TA indicator(s).

  • AIMD’s TA Score: 3 bullish, 6 bearish.
  • CODX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CODX is a better buy in the short-term than AIMD.

Price Growth

AIMD (@Medical Specialties) experienced а -8.50% price change this week, while CODX (@Medical Specialties) price change was -7.02% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Reported Earning Dates

AIMD is expected to report earnings on Feb 28, 2024.

CODX is expected to report earnings on Apr 08, 2025.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CODX($34.7M) has a higher market cap than AIMD($6.73M). CODX YTD gains are higher at: -20.301 vs. AIMD (-78.585). AIMD has higher annual earnings (EBITDA): -8.75M vs. CODX (-41.48M). CODX has more cash in the bank: 58.5M vs. AIMD (1.89M). CODX has less debt than AIMD: CODX (2.99M) vs AIMD (5.96M). CODX has higher revenues than AIMD: CODX (6.81M) vs AIMD (122K).
AIMDCODXAIMD / CODX
Capitalization6.73M34.7M19%
EBITDA-8.75M-41.48M21%
Gain YTD-78.585-20.301387%
P/E RatioN/A6.17-
Revenue122K6.81M2%
Total Cash1.89M58.5M3%
Total Debt5.96M2.99M199%
FUNDAMENTALS RATINGS
AIMD vs CODX: Fundamental Ratings
AIMD
CODX
OUTLOOK RATING
1..100
9673
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
49
Fair valued
PROFIT vs RISK RATING
1..100
10099
SMR RATING
1..100
9695
PRICE GROWTH RATING
1..100
9380
P/E GROWTH RATING
1..100
10026
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AIMD's Valuation (43) in the null industry is in the same range as CODX (49) in the Biotechnology industry. This means that AIMD’s stock grew similarly to CODX’s over the last 12 months.

CODX's Profit vs Risk Rating (99) in the Biotechnology industry is in the same range as AIMD (100) in the null industry. This means that CODX’s stock grew similarly to AIMD’s over the last 12 months.

CODX's SMR Rating (95) in the Biotechnology industry is in the same range as AIMD (96) in the null industry. This means that CODX’s stock grew similarly to AIMD’s over the last 12 months.

CODX's Price Growth Rating (80) in the Biotechnology industry is in the same range as AIMD (93) in the null industry. This means that CODX’s stock grew similarly to AIMD’s over the last 12 months.

CODX's P/E Growth Rating (26) in the Biotechnology industry is significantly better than the same rating for AIMD (100) in the null industry. This means that CODX’s stock grew significantly faster than AIMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AIMDCODX
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
76%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend about 1 month ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 18 days ago
90%
Bullish Trend 3 days ago
79%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
View a ticker or compare two or three
Ad is loading...
AIMD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CODX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CENT36.920.16
+0.44%
Central Garden & Pet Company
MNTX5.730.02
+0.35%
Manitex International
PATH12.37-0.27
-2.14%
UiPath
HSII44.78-1.59
-3.43%
Heidrick & Struggles International
EZGO0.92-0.04
-4.06%
EZGO Technologies Ltd

AIMD and

Correlation & Price change

A.I.dvisor tells us that AIMD and CRMD have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AIMD and CRMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AIMD
1D Price
Change %
AIMD100%
-8.75%
CRMD - AIMD
28%
Poorly correlated
-6.09%
XLO - AIMD
26%
Poorly correlated
+8.64%
RGEN - AIMD
22%
Poorly correlated
-12.43%
CODX - AIMD
21%
Poorly correlated
-3.64%
AXGN - AIMD
21%
Poorly correlated
+1.36%
More

CODX and

Correlation & Price change

A.I.dvisor tells us that CODX and ILMN have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CODX and ILMN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CODX
1D Price
Change %
CODX100%
-3.64%
ILMN - CODX
31%
Poorly correlated
-5.05%
AEMD - CODX
30%
Poorly correlated
+0.20%
BNGO - CODX
26%
Poorly correlated
-3.83%
APDN - CODX
25%
Poorly correlated
-6.79%
CORBF - CODX
25%
Poorly correlated
+4.00%
More